Neoadjuvant Chemotherapy with FOLFOX4 Regimen to Treat Advanced Gastric Cancer Improves Survival without Increasing Adverse Events: A Retrospective Cohort Study from a Chinese Center

Background/Aim. To evaluate the clinical efficacy of FOLFOX4 (5-fluomumcil/leucovorin combined and oxaliplatin) neoadjuvant chemotherapy for advanced gastric cancer (AGC). Patients and Methods. Fifty-eight AGC patients were enrolled in this retrospective cohort study, 23 in the neoadjuvant group and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhen, Zhu, Rui-Juan, Yang, Gui-Fang, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127276/
https://www.ncbi.nlm.nih.gov/pubmed/25136668
http://dx.doi.org/10.1155/2014/418694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127276/
https://www.ncbi.nlm.nih.gov/pubmed/25136668
http://dx.doi.org/10.1155/2014/418694

Ejemplares similares